Ocugen (OCGN) Change in Accured Expenses (2014 - 2026)

Ocugen (OCGN) posted Change in Accured Expenses of -$5.4 million for Q1 2026, down 547.6% on a QoQ basis from $1.2 million in Q4 2025, and down 65.18% year-over-year from -$15.5 million in Q1 2025.

Ocugen (OCGN) Change in Accured Expenses (2014 - 2026) Analysis & Trends

Ocugen's Change in Accured Expenses history runs 13 years deep, the most recent figure standing at -$5.4 million for Q1 2026.

  • Quarterly Change in Accured Expenses fell 65.18% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 48.98% YoY) and the FY2025 annual result came in at $3.3 million, down 19.97% from the prior year.
  • Change in Accured Expenses was -$5.4 million for Q1 2026 at Ocugen, down from $1.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.9 million in Q3 2022 and bottomed at -$5.4 million in Q1 2026.
  • A 5-year average of -$47411.8 and a median of $1.2 million in 2025 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 380.45% — and 2023, when it plunged 3889.31%.
  • Ocugen's Change in Accured Expenses stood at $2.8 million in 2022, then plunged by 170.5% to -$1.9 million in 2023, then surged by 207.62% to $2.1 million in 2024, then plunged by 42.27% to $1.2 million in 2025, then slumped by 547.6% to -$5.4 million in 2026.
  • Business Quant data shows OCGN's Change in Accured Expenses at -$5.4 million in Q1 2026, $1.2 million in Q4 2025, and $3.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn - 1.13 Mn
2 Nanobiotix 1,899.87 Bn 1,899.81 Bn - -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - 931,000.00
4 BeOne Medicines 470.43 Bn 465.64 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 123.43 Bn 116.19 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 70.20 Bn 61.44 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 61.75 Bn 61.75 Bn - -
8 Argenx Se 56.15 Bn 50.96 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn -176.03 Mn
10 Ocugen 411.07 Mn 411.07 Mn - -5.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.40 Mn
Mar 31, 2026 -5.40 Mn
Dec 31, 2025 1.21 Mn
Dec 31, 2025 1.21 Mn
Sep 30, 2025 3.29 Mn
Sep 30, 2025 3.29 Mn
Jun 30, 2025 2.08 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 -3.27 Mn
Mar 31, 2025 -3.27 Mn
Dec 31, 2024 2.09 Mn
Dec 31, 2024 2.09 Mn
Sep 30, 2024 2.16 Mn
Sep 30, 2024 2.16 Mn
Jun 30, 2024 1.33 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 -1.45 Mn
Mar 31, 2024 -1.45 Mn
Dec 31, 2023 -1.94 Mn
Dec 31, 2023 -1.94 Mn